바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.76 No.4
Citation Share

Single Pleural Relapse of a Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma: A Case Report

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2014, v.76 no.4, pp.184-187








& (2014). Single Pleural Relapse of a Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma: A Case Report. Tuberculosis & Respiratory Diseases, 76(4), 184-187.
  • Downloaded
  • Viewed
PDF Download

Abstract

A nasal-type extranodal natural killer/T-cell lymphoma is considered an aggressive form of non-Hodgkin’s lymphoma, with approximately half of all patients relapsing during the follow-up period, and most relapses occurring within the first 2 years of remission. Here we report an unusual case of a 42-year-old man who experienced recurrence in single pleura after 8 years of remission.

keywords
Pleural Effusion, Adenosine Deaminase, Lymphoma, Extranodal NK-T-Cell

Reference

1.

1. Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612-8.

2.

2. Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000;18:54-63.

3.

3. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005;19:2186-94.

4.

4. Au WY, Kim SJ, Yiu HH, Ngan RK, Loong F, Kim WS, et al. Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission. Am J Hematol 2010;85:362-3.

5.

5. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009:523-31.

6.

6. Kim J, Kim EY, Lee SK, Kim DI, Kim CH, Kim SH, et al. Extranodal nasal-type NK/T-cell lymphoma: computed tomography findings of head and neck involvement. Acta Radiol 2010;51:164-9.

7.

7. Berkman N, Breuer R, Kramer MR, Polliack A. Pulmonary involvement in lymphoma. Leuk Lymphoma 1996;20:229-37.

8.

8. Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 2006;34:335-47.

9.

9. Valdes L, Alvarez D, Valle JM, Pose A, San Jose E. The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 1996;109:158-62.

10.

10. Valdes L, Alvarez D, San Jose E, Penela P, Valle JM, Garcia-Pazos JM, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998;158:2017-21.

11.

11. Lee YC, Rogers JT, Rodriguez RM, Miller KD, Light RW. Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 2001;120:356-61.

12.

12. Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li CP, et al. Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study. Int J Tuberc Lung Dis 2011;15:125-30.

13.

13. Falagas ME, Kouranos VD, Athanassa Z, Kopterides P. Tuberculosis and malignancy. QJM 2010;103:461-87.

14.

14. Lanjewar DN, Lanjewar SD, Chavan G. Coexistent lymphoma with tuberculosis and Kaposi’s sarcoma with tuberculosis occurring in lymph node in patients with AIDS: a report of two cases. Indian J Pathol Microbiol 2010;53:551-4.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy